Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
boston blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
europe blog main
5
×
europe top stories
fda
5
×
gilead sciences
5
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston top stories
cancer immunotherapy
startups
alzheimer's disease
amag pharmaceuticals
astrazeneca
deals
gene therapy
nonalcoholic steatohepatitis
novartis
What
bio
roundup
cancer
amid
bombast
caught
coronavirus
covid
debate
develop
discussion
efforts
ipo
medicines
meso’s
miss
pandemic
pfizer’s
presidential
promise
response
tuesday’s
vaccine
viewers
abbvie’s
acquisitions
activity
ahead
announced
approvals
biofourmis
biogen
bucks
celebrate
ceo
chance
clamped
collabs
corner
daniel
Language
unset
Current search:
fda
×
biotech
×
" europe blog main "
×
" gilead sciences "
×
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More